CNMD Stock Cash Flow Statements

CONMED Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

CONMED Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31

cash flows from operating activities:
net income	21,421,000	6,036,000	33,755,000	48,983,000	29,976,000	19,709,000	33,071,000	15,837,000	13,732,000	1,819,000	26,584,000	46,150,000	-168,291,000	14,975,000	24,444,000	14,948,000	13,290,000	9,860,000	24,140,000	6,850,000	-27,400,000	5,927,000	14,934,000	6,970,000	5,695,000	1,021,000	15,653,000	5,825,000	8,719,000	10,657,000	46,696,000	7,197,000	6,139,000	-4,545,000	6,708,000	7,337,000	2,884,000	-2,265,000	7,852,000	8,873,000	7,461,000	6,312,000	11,339,000	1,972,000	10,255,000	8,626,000	10,227,000	5,687,000	9,533,000	10,492,000	10,897,000	9,320,000	10,296,000	9,968,000	-25,134,000	8,211,000	8,680,000	8,995,000	6,963,000	8,758,000	7,306,000	7,319,000	1,288,000	1,409,000	4,485,000	10,577,000	10,519,000	12,455,000	11,010,000	11,834,000	8,355,000	9,345,000	11,922,000	-23,593,000	3,332,000	3,414,000	4,340,000	2,807,000
adjustments to reconcile net income to net cash from operating activities:
depreciation	4,466,000	4,235,000	4,199,000	4,195,000	4,165,000	4,046,000	4,052,000	3,926,000	4,165,000	4,057,000	4,027,000	3,938,000	4,058,000	4,032,000	3,975,000	3,778,000	3,984,000	4,757,000	4,427,000	4,383,000	4,588,000	4,646,000	4,463,000	5,258,000	4,525,000	4,442,000	4,649,000	4,875,000	4,504,000	4,502,000	5,086,000	5,235,000	4,892,000	4,866,000	5,237,000	5,301,000	4,955,000	4,986,000	4,785,000	4,723,000	4,563,000	4,633,000	5,090,000	5,229,000	4,905,000	4,568,000	4,952,000	4,533,000	4,549,000	4,619,000	4,617,000	4,744,000	4,586,000	4,688,000	4,819,000	4,717,000	4,567,000	4,416,000	4,529,000	4,414,000	4,302,000	4,147,000	5,030,000	4,270,000	4,011,000	4,051,000	3,969,000	3,316,000	3,305,000	3,603,000	3,364,000	3,075,000	3,059,000	3,147,000	3,069,000	2,799,000	2,723,000	3,163,000
amortization of deferred debt issuance costs	1,388,000	1,443,000	1,444,000	1,443,000	1,406,000	1,407,000	1,500,000	1,546,000	1,506,000	1,506,000	1,506,000	1,488,000	1,036,000	880,000	780,000	830,000	1,058,000	1,058,000	1,026,000	1,011,000	867,000	819,000
amortization	14,105,000	14,018,000	13,807,000	13,779,000	13,674,000	13,992,000	13,950,000	13,947,000	13,900,000	13,877,000	13,710,000	13,689,000	13,266,000	12,799,000	13,502,000	13,431,000	13,797,000	13,519,000	13,608,000	13,581,000	13,616,000	13,776,000	12,263,000	14,296,000	14,171,000	12,905,000	10,944,000	10,837,000	10,743,000	10,749,000	10,400,000	9,627,000	9,384,000	9,058,000	8,862,000	8,618,000	9,078,000	8,272,000	6,786,000	6,504,000	6,348,000	5,537,000	6,624,000	6,487,000	6,531,000	6,300,000		7,192,000	7,538,000	7,110,000																4,438,000	4,349,000	4,384,000	4,524,000	4,418,000	4,749,000	4,693,000	4,573,000	4,409,000	4,556,000	4,543,000	4,605,000	4,699,000
stock-based compensation	4,903,000	13,863,000	6,222,000	6,122,000	6,974,000	6,240,000	5,923,000	6,186,000	6,422,000	5,726,000	5,757,000	5,754,000	5,755,000	4,463,000	4,332,000	4,327,000	4,289,000	3,387,000	2,992,000	3,532,000	3,555,000	3,032,000	2,960,000	3,008,000	3,108,000	2,703,000	2,572,000	2,512,000	2,650,000	2,303,000	2,132,000	2,119,000	2,266,000	1,955,000	1,870,000	1,922,000	2,094,000	2,489,000	1,938,000	1,782,000	1,923,000	1,856,000	1,639,000	5,173,000	1,333,000	1,185,000	1,491,000	1,606,000	1,344,000	1,152,000								1,026,000	959,000			940,000			974,000	963,000			942,000	839,000				1,110,000
deferred income taxes	1,684,000	-2,659,000	6,576,000	2,520,000	1,241,000	1,865,000	1,591,000	-284,000	533,000	-1,140,000	-44,484,000	-31,960,000	70,225,000	177,000	4,316,000	470,000	907,000	-2,688,000	-13,448,000	8,704,000	-6,748,000	-2,742,000	-804,000	748,000	-1,555,000	-4,699,000	3,331,000	-1,386,000	854,000	-736,000	-34,892,000	-854,000	-9,000	-4,266,000	1,106,000	365,000	-1,400,000	-2,942,000	-1,908,000	1,983,000	923,000	1,253,000	837,000	-4,958,000	512,000	3,325,000	416,000	1,764,000	3,124,000	1,914,000	1,194,000	5,661,000	3,356,000	2,735,000	-25,059,000	2,980,000	4,356,000	4,625,000	2,522,000	3,397,000	3,641,000	3,598,000	-324,000	594,000	2,535,000	1,003,000	5,621,000	6,581,000	5,779,000	1,845,000	4,399,000	4,293,000	6,177,000	-16,959,000	1,020,000	1,529,000	2,121,000	-882,000
non-cash adjustments to fair value of contingent consideration liability	-1,799,000	3,962,000	1,219,000	-27,048,000
loss on early extinguishment of debt											0	0			0								0	0	0	300,000									0	0	0	254,000									0	0	0	263,000
accounts receivable	-7,837,000	18,984,000	-12,400,000	10,775,000	914,000	-908,000	-9,053,000	-2,831,000	-14,518,000	-20,666,000	10,889,000	1,687,000	-17,616,000	-163,000	-19,049,000	2,110,000	-4,177,000	11,957,000	-7,654,000	-22,158,000	24,675,000	19,057,000	-24,699,000	3,821,000	-6,798,000	13,733,000	-21,821,000	855,000	-6,639,000	10,145,000	-19,841,000	-88,000	-3,944,000	10,242,000	-17,715,000	6,406,000	-6,499,000	11,428,000	-9,953,000	3,881,000	234,000	-3,805,000	-8,444,000	8,115,000	-5,052,000	10,636,000	-9,609,000	11,500,000	-5,731,000	3,042,000	-5,223,000	7,937,000	4,591,000	-5,618,000	-6,281,000	19,286,000	-4,631,000	90,000	-4,258,000	4,882,000	3,340,000	5,378,000	-13,325,000	2,527,000	5,472,000	-2,337,000	3,370,000	-1,286,000	-3,482,000	-3,877,000	1,500,000	-1,259,000	-2,665,000	-3,446,000	913,000	-2,760,000	5,167,000	1,431,000
inventories	-5,551,000	-7,475,000	-7,197,000	-18,641,000	-746,000	-5,049,000	8,785,000	818,000	7,484,000	-3,016,000	-26,438,000	-16,577,000	-13,692,000	-21,857,000	-3,127,000	-17,986,000	-5,055,000	-11,638,000	-11,001,000	-6,367,000	-716,000	-12,313,000	15,528,000	-1,836,000	-1,838,000	-11,971,000	-1,360,000	-10,663,000	1,601,000	-4,615,000	8,136,000	-12,634,000	3,946,000	-3,374,000	25,244,000	-11,655,000	234,000	-10,720,000	-9,407,000	-17,126,000	-6,848,000	-1,155,000	9,083,000	-10,860,000	-7,227,000	-11,936,000	3,764,000	-4,000,000	3,277,000	-4,858,000	6,246,000	-5,514,000	314,000	2,764,000	2,918,000	-10,846,000	-342,000	420,000	7,881,000	-12,031,000	-8,165,000	-8,002,000	-3,274,000	-928,000	-3,391,000	-5,137,000	-6,001,000	1,702,000	1,326,000	-795,000	-6,676,000	-10,512,000	-4,638,000	595,000	-3,614,000	1,475,000	-7,836,000	-2,508,000
accounts payable	5,703,000	-7,317,000	-632,000	2,045,000	301,000	12,999,000	6,716,000	3,680,000	1,754,000	2,699,000	-1,173,000	751,000	4,519,000	9,205,000	11,113,000	-8,770,000	-257,000	2,804,000	-4,454,000	17,180,000	-17,408,000	1,705,000	10,142,000	-5,026,000	-3,302,000	-1,776,000	5,897,000	-3,769,000	1,975,000	8,006,000	-8,087,000	3,408,000	-809,000	5,202,000	5,514,000	4,213,000	3,476,000	-11,109,000	3,516,000	4,129,000	130,000	3,733,000	-5,261,000	3,165,000	-202,000	-1,151,000	2,204,000	4,226,000	-2,520,000	313,000	-1,434,000	348,000	-1,256,000	2,601,000	364,000	-24,000	527,000	1,782,000	-4,344,000	-6,401,000	2,264,000	3,836,000	5,846,000	-3,131,000	-4,643,000	-983,000	-761,000	-5,463,000	164,000	2,870,000	-2,705,000	944,000	-3,523,000	2,951,000	2,692,000	-1,397,000	2,770,000	-3,672,000
accrued compensation and benefits	9,111,000	-8,181,000	5,229,000	5,907,000	5,859,000	-19,829,000	8,964,000	5,714,000	5,469,000	-5,722,000	-707,000	3,999,000	2,706,000	-14,966,000	6,037,000	5,799,000	8,186,000	-8,955,000	4,741,000	7,782,000	1,751,000	-18,397,000	8,229,000	8,707,000	6,716,000	-13,695,000	8,579,000	2,836,000	4,681,000	-7,052,000	5,487,000	2,082,000	1,432,000	-8,665,000	1,104,000	1,056,000	2,761,000	-7,519,000	3,076,000	-962,000	-1,593,000	-4,485,000	6,079,000	2,753,000	3,904,000	-9,164,000	7,281,000	41,000	1,437,000	-8,830,000	6,002,000	1,495,000	3,716,000	-10,446,000	4,180,000	3,177,000	1,758,000	-7,442,000	1,917,000	509,000	3,599,000	-3,509,000	5,861,000	-3,037,000	41,000	-3,430,000	4,035,000	730,000	-1,573,000	1,272,000	3,128,000	601,000	-2,989,000	3,103,000	1,589,000	529,000	30,000	929,000
other assets	-4,452,000	-5,422,000	-3,617,000	-2,707,000	-805,000	-6,781,000	133,000	-10,071,000	-535,000	-11,372,000	-6,025,000	-322,000	-5,259,000	-6,129,000	-8,090,000	-3,626,000	-6,287,000	-6,002,000	-2,157,000	-2,379,000	3,626,000	-7,260,000	-9,061,000	737,000	-3,892,000	-10,047,000	-3,893,000	-4,017,000	-6,548,000	-9,758,000	-4,484,000	-2,912,000	-6,848,000	-8,157,000	-20,192,000	2,332,000	2,288,000	-7,662,000	1,519,000	-172,000	-314,000	2,917,000	-921,000	-459,000	-1,254,000	2,088,000	-2,586,000	1,078,000	-1,291,000	-2,423,000	1,513,000	-944,000	-673,000	-1,106,000	-1,346,000	-671,000	-309,000	-1,917,000	929,000	2,287,000	-2,019,000	-865,000	-398,000	-697,000	-133,000	-2,503,000	-885,000	638,000	-1,719,000	215,000	-917,000	-402,000	1,021,000	-499,000	-259,000	-253,000	-571,000	-1,033,000
other liabilities	-14,371,000	10,047,000	-5,074,000	3,830,000	-10,979,000	7,975,000	-5,946,000	4,509,000	-12,602,000	3,949,000	-4,488,000	-2,704,000	10,024,000	-3,088,000	-5,379,000	2,572,000	2,016,000	1,782,000	7,116,000	578,000	2,587,000	-6,793,000	3,070,000	-2,659,000	2,483,000	1,654,000	2,345,000	-7,766,000	-1,915,000	821,000	5,891,000	248,000	-421,000	12,982,000	-3,675,000	757,000	-2,714,000	-2,492,000	2,469,000	-903,000	-801,000	-2,662,000	-4,540,000	-3,905,000	-2,978,000	722,000	54,000	-1,052,000	-2,163,000	-7,566,000	12,000	-157,000	-3,982,000	-5,032,000	86,000	1,450,000	-2,239,000	2,448,000	42,000	-2,875,000	-3,526,000	-2,289,000	4,942,000	-1,692,000	-969,000	3,005,000	-1,639,000	-1,121,000	-5,278,000	4,503,000	-1,599,000	-394,000	342,000	-1,432,000	1,462,000	1,619,000	2,523,000	-4,702,000
net cash from operating activities	29,134,000	41,534,000	43,338,000	51,203,000	43,306,000	29,121,000	56,395,000	46,127,000	26,673,000	-3,847,000	-11,598,000	25,893,000	18,742,000	328,000	33,785,000	21,362,000	34,279,000	22,344,000	20,145,000	35,126,000	5,539,000	3,721,000	40,876,000	36,600,000	21,577,000	-3,920,000	24,703,000	4,351,000	20,625,000	25,022,000	20,812,000	13,428,000	16,028,000	15,298,000	13,583,000	24,762,000	17,157,000	-17,280,000	9,348,000	13,665,000	10,246,000	14,809,000	25,647,000	14,616,000	7,888,000	17,025,000	27,311,000	30,484,000	17,682,000	5,472,000	33,936,000	27,986,000	25,648,000	7,629,000	26,284,000	36,486,000	19,523,000	20,700,000	22,953,000	9,767,000			11,792,000	7,271,000	6,716,000	5,318,000	20,745,000	14,332,000	20,754,000	30,431,000	9,665,000	14,582,000	11,216,000	23,775,000	13,332,000	13,454,000	14,011,000	3,642,000
capex	-5,729,000	-3,779,000	-4,040,000	-3,419,000	-3,590,000	-2,035,000	-4,855,000	-5,394,000	-4,529,000	-4,254,000	-5,676,000	-6,711,000	-5,711,000	-3,687,000	-3,188,000	-5,575,000	-2,994,000	-3,109,000	-3,149,000	-3,287,000	-3,752,000	-2,825,000	-6,191,000	-4,869,000	-4,984,000	-4,022,000	-4,756,000	-4,460,000	-3,508,000	-3,783,000	-3,610,000	-3,707,000	-2,941,000	-2,584,000	-4,317,000	-2,769,000	-4,878,000	-2,789,000	-3,531,000	-3,695,000	-3,722,000	-4,061,000	-3,161,000	-3,609,000	-4,576,000	-4,065,000	-4,893,000	-5,351,000	-4,071,000	-4,130,000	-5,563,000	-4,373,000	-5,172,000	-6,424,000	-4,880,000	-4,096,000	-4,433,000	-4,143,000	0	-3,692,000			-5,058,000	0	-7,441,000	0	-6,640,000	0	-5,975,000	0	-6,408,000	0	-3,868,000	0	-6,491,000	0	-4,908,000	0
free cash flows	23,405,000	37,755,000	39,298,000	47,784,000	39,716,000	27,086,000	51,540,000	40,733,000	22,144,000	-8,101,000	-17,274,000	19,182,000	13,031,000	-3,359,000	30,597,000	15,787,000	31,285,000	19,235,000	16,996,000	31,839,000	1,787,000	896,000	34,685,000	31,731,000	16,593,000	-7,942,000	19,947,000	-109,000	17,117,000	21,239,000	17,202,000	9,721,000	13,087,000	12,714,000	9,266,000	21,993,000	12,279,000	-20,069,000	5,817,000	9,970,000	6,524,000	10,748,000	22,486,000	11,007,000	3,312,000	12,960,000	22,418,000	25,133,000	13,611,000	1,342,000	28,373,000	23,613,000	20,476,000	1,205,000	21,404,000	32,390,000	15,090,000	16,557,000	22,953,000	6,075,000			6,734,000	7,271,000	-725,000	5,318,000	14,105,000	14,332,000	14,779,000	30,431,000	3,257,000	14,582,000	7,348,000	23,775,000	6,841,000	13,454,000	9,103,000	3,642,000
cash flows from investing activities:
purchases of property, plant and equipment	-5,729,000	-3,779,000	-4,040,000	-3,419,000	-3,590,000	-2,035,000	-4,855,000	-5,394,000	-4,529,000	-4,254,000	-5,676,000	-6,711,000	-5,711,000	-3,687,000	-3,188,000	-5,575,000	-2,994,000	-3,109,000	-3,149,000	-3,287,000	-3,752,000	-2,825,000	-6,191,000	-4,869,000	-4,984,000	-4,022,000	-4,756,000	-4,460,000	-3,508,000	-3,783,000	-3,610,000	-3,707,000	-2,941,000	-2,584,000	-4,317,000	-2,769,000	-4,878,000	-2,789,000	-3,531,000	-3,695,000	-3,722,000	-4,061,000	-3,161,000	-3,609,000	-4,576,000	-4,065,000	-4,893,000	-5,351,000	-4,071,000	-4,130,000	-5,563,000	-4,373,000	-5,172,000	-6,424,000	-4,880,000	-4,096,000	-4,433,000	-4,143,000				-3,333,000			-7,441,000				-5,975,000				-3,868,000				-4,908,000
other	0	850,000				67,000	0	0	-3,448,000	2,448,000	1,408,000	610,000	315,000	6,142,000	1,716,000	-1,445,000	2,686,000	8,216,000	6,563,000	1,360,000	42,000	-5,132,000	626,000	1,828,000	-173,000	1,655,000	1,070,000	359,000	107,000	577,000	515,000	331,000	-706,000	-512,000	191,000	191,000	99,000	110,000		-847,000	1,236,000	362,000		1,363,000	1,719,000	138,000	-3,799,000	-4,115,000	5,465,000	1,625,000	-7,109,000	608,000	4,116,000	809,000
net cash from investing activities	-5,729,000	-2,929,000	-4,040,000	-3,419,000	-3,590,000	-2,035,000	-4,855,000	-5,394,000	-5,529,000	-4,254,000	-6,318,000	-91,258,000	-148,266,000	-3,687,000	-3,188,000	-5,575,000	-2,994,000	-3,109,000	-3,149,000	-60,000	-3,752,000	-6,677,000	-8,859,000	-4,869,000	-4,984,000	-368,950,000	-4,756,000	-4,460,000	-3,508,000	-3,783,000	-4,628,000	-17,136,000	-4,706,000	-2,584,000	-4,317,000	2,409,000	-4,904,000	-259,213,000	-6,780,000	-3,695,000	-8,973,000	-4,914,000	-7,181,000	-4,854,000	-4,576,000	-4,065,000	-4,893,000	-5,351,000	-4,071,000	-4,130,000	-7,137,000	-23,100,000	-5,172,000	-70,540,000	-8,999,000	-4,096,000	-4,433,000	-4,215,000	-3,940,000	-3,761,000	-3,904,000	-8,416,000	-5,132,000	-4,667,000	-7,553,000	-14,017,000	-6,835,000	-16,317,000	-20,733,000	-5,042,000	-10,967,000	-6,083,000	-4,751,000	-5,160,000	-6,496,000	-7,797,000	-3,703,000	-4,017,000
cash flows from financing activities:
payments on term loan	-40,233,000	-14,588,000									0	0	-90,000,000	-2,981,000	-2,981,000	-55,392,000	-4,968,000	-3,313,000	-3,312,000	-3,313,000	-3,312,000	-3,313,000	-3,312,000	-3,312,000	-3,313,000	-144,375,000	-3,281,000	-3,281,000	-3,282,000	-3,281,000	-2,187,000	-2,188,000	-2,187,000	-2,188,000	-2,186,000
proceeds from term loan															0								0	0	0	265,000,000									0
payments on revolving line of credit	-171,432,000	-166,000,000	-186,000,000	-169,000,000	-230,000,000	-168,000,000	-200,000,000	-213,000,000	-183,000,000	-164,000,000	-126,000,000	-92,000,000	-213,000,000	-99,000,000	-121,000,000	-111,753,000	-89,000,000	-72,000,000	-70,000,000	-72,000,000	-29,000,000	-41,000,000	-49,000,000	-42,000,000	-51,000,000	-342,000,000	-49,000,000	-32,000,000	-38,000,000	-49,000,000	-59,000,000	-30,000,000	-32,000,000	-36,000,000
proceeds from revolving line of credit	175,432,000	166,000,000	150,000,000	143,000,000	204,000,000	254,000,000	180,000,000	181,000,000	158,000,000	173,000,000	143,000,000	145,000,000	62,000,000	110,000,000	90,000,000	97,753,000	75,000,000	64,000,000	47,000,000	44,000,000	49,000,000	59,000,000	22,000,000	27,000,000	44,000,000	299,000,000	49,000,000	47,000,000	33,000,000	24,000,000	40,000,000	44,000,000	33,000,000	38,000,000	163,346,000
payments to redeem convertible notes			0	0	0	-70,000,000					0	0
payments related to contingent consideration	-6,928,000	-7,166,000	-8,795,000	-8,655,000	-12,501,000	-26,928,000								-798,000	-2,686,000				-600,000	0	-938,000	-1,133,000	-779,000	-1,282,000	-1,546,000	-2,859,000										0
payments related to debt issuance costs											0	-643,000			0				-1,096,000	0			0	0	0	-16,210,000									0	0	0	-5,556,000	-75,000	0
dividends paid on common stock	-6,186,000	-6,180,000	-6,177,000	-6,163,000	-6,158,000	-6,153,000	-6,149,000	-6,145,000	-6,110,000	-6,098,000	-6,095,000	-6,092,000	-5,899,000	-5,874,000	-5,838,000	-5,830,000	-5,813,000	-5,775,000	-5,719,000	-5,712,000	-5,704,000	-5,683,000	-5,673,000	-5,658,000	-5,643,000	-5,626,000	-5,624,000	-5,621,000	-5,606,000	-5,592,000	-5,585,000	-5,584,000	-5,572,000	-5,566,000	-5,564,000	-5,561,000	-5,546,000	-5,542,000	-5,540,000	-5,539,000	-5,516,000	-5,510,000	-5,504,000	-5,468,000	-5,442,000	-5,545,000	-4,128,000	-4,123,000	-4,189,000	-4,256,000	-4,272,000	-4,262,000
net cash from financing activities	-26,527,000	-28,398,000	-51,070,000	-38,831,000	-44,085,000	-17,014,000	-58,766,000	-37,229,000	-19,787,000	5,350,000	11,515,000	46,875,000	159,121,000	7,489,000	-40,789,000	-29,792,000	-22,095,000	-8,872,000	-27,164,000	-35,665,000	8,031,000	2,739,000	-36,974,000	-23,424,000	-17,675,000	378,954,000	-31,645,000	6,457,000	-13,781,000	-33,296,000	-27,709,000	6,559,000	-7,465,000	-6,266,000	-7,216,000	-23,919,000	-7,825,000	223,162,000	5,482,000	-4,190,000	-6,431,000	-4,634,000	-13,784,000	-1,342,000	-57,000	-11,207,000	-17,534,000	-14,577,000	-6,819,000	7,634,000								-11,713,000	-22,650,000	806,000	-15,161,000	21,399,000			1,033,000					-19,824,000	848,000	-10,212,000	-6,217,000		786,000	-6,069,000	-9,269,000
effect of exchange rate changes on cash and cash equivalents	1,572,000	819,000	-2,236,000	645,000	-617,000	-513,000	1,020,000	-850,000	-3,000	303,000	1,989,000	-1,308,000	-1,309,000	-113,000	-472,000	-872,000	429,000	-950,000	1,926,000	1,214,000	856,000	-1,330,000	745,000	-788,000	224,000	-188,000	-482,000	-58,000	-1,066,000	566,000	113,000	1,042,000	1,624,000	784,000		401,000	-1,027,000	721,000		-2,670,000	1,645,000	-5,864,000
net increase in cash and cash equivalents	-1,550,000	11,026,000	-14,008,000	9,598,000	-4,986,000	9,559,000	-6,206,000	2,654,000	1,354,000	-2,448,000	-4,412,000	-19,798,000	28,288,000	4,017,000	-10,664,000	-14,877,000	9,619,000	9,413,000	-8,242,000	615,000	10,674,000	-1,547,000	-4,212,000	7,519,000	-858,000	5,896,000	-12,180,000	6,290,000	2,270,000	-11,491,000	-11,412,000	3,893,000	5,481,000	7,232,000						3,110,000	-3,513,000	-603,000		4,200,000	4,096,000	1,875,000		11,708,000	5,764,000	8,639,000		3,573,000	-3,208,000	-6,594,000		15,552,000	6,392,000	5,522,000				-128,000	3,538,000	-1,499,000	367,000	-20,087,000	14,048,000	4,442,000	1,713,000	6,284,000	1,532,000	-658,000	706,000				1,199,000
cash and cash equivalents at beginning of period	0	24,459,000		0	0	24,296,000		0	0	28,942,000		0	0	20,847,000		0	0	27,356,000		0	0	25,856,000		0	0	17,511,000		0	0	32,622,000		0	0	27,428,000		0	0	72,504,000		0	0	66,332,000		0	0	54,443,000		0	0	23,720,000		0	0	26,048,000		0	0	12,417,000		0	0	10,098,000	0	0	11,811,000		0	0	11,695,000		0	0	3,831,000		0	0	3,454,000
cash and cash equivalents at end of period	-1,550,000	35,485,000		9,598,000	-4,986,000	33,855,000		2,654,000	1,354,000	26,494,000		-19,798,000	28,288,000	24,864,000		-14,877,000	9,619,000	36,769,000		615,000	10,674,000	24,309,000		7,519,000	-858,000	23,407,000		6,290,000	2,270,000	21,131,000		3,893,000	5,481,000	34,660,000		3,653,000	3,401,000	19,894,000		3,110,000	-3,513,000	65,729,000		4,200,000	4,096,000	56,318,000		11,708,000	5,764,000	32,359,000		3,573,000	-3,208,000	19,454,000		15,552,000	6,392,000	17,939,000		8,034,000	-1,480,000	9,970,000	3,538,000	-1,499,000	12,178,000		14,048,000	4,442,000	13,408,000		1,532,000	-658,000	4,537,000		8,412,000	427,000	4,653,000
non-cash financing activities:
dividends payable	3,000	6,186,000		15,000	5,000	6,158,000		4,000	32,000	6,113,000		3,000	193,000	5,899,000		7,000	17,000	5,813,000		8,000	9,000	5,703,000		16,000	14,000	5,643,000	1,000	5,000	14,000	5,606,000		1,000	11,000	5,573,000		0	15,000	5,546,000		1,000	23,000	5,516,000		36,000	26,000	5,442,000	1,417,000	5,000	-66,000	4,189,000	-16,000	10,000	-66,000	4,328,000
increase in cash flows from changes in assets and liabilities:
loss on convertible notes conversion premium											0	0
loss on convertible notes hedge transactions settlement											0	0
increase in cash flows from changes in assets and
liabilities, net of acquired assets:
income taxes
payments related to business acquisitions, net of cash acquired																																				0	-26,000	-256,424,000
proceeds from convertible notes																							0	0	0	345,000,000
purchases of convertible notes hedges
proceeds from issuance of warrants											0	0											0	0	0	30,567,000
proceeds from settlement of convertible notes hedge transactions											0	0
payment for settlement of warrants											0	0
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
non-cash adjustment to fair value of contingent consideration liability						-6,545,000	-9,370,000	3,150,000	-637,000	4,436,000
non-cash investing and financing activities:
amortization of debt discount															2,606,000	2,580,000	2,528,000	2,503,000	2,453,000	2,429,000	2,546,000	2,264,000	2,264,000	2,264,000	2,264,000	1,510,000																													565,000	1,131,000	1,113,000	1,094,000	1,077,000	1,059,000	1,056,000	1,052,000	1,018,000	1,013,000	1,045,000
proceeds from issuance of convertible notes												0
purchases of convertible notes hedge transactions												0
contingent consideration												114,512,000
payments related to business acquisition, net of cash acquired												-84,547,000												0	0	-364,928,000
payments related to business and asset acquisitions, net of cash acquired																			0	0	0	-3,852,000									-1,018,000
proceeds from sale of a facility																			0																0
impairment charges																							0				0
payments on mortgage notes																																							-629,000	0							-535,000	0			-494,000	0			-456,000	0			-420,000	0			-1,000							-724,000	205,000			-644,000	189,000			-573,000
purchases of convertible hedges																								0	0	-51,198,000
contractual obligations from asset acquisition																										5,500,000	-17,489,000	0	15,849,000	10,000,000
gain on sale of facility																																			0
payments related to distribution agreement																																			0	0	0	-16,667,000	0	0	0	-16,667,000	0
non-cash investing activities:
income tax benefit of stock option exercises
excess tax benefit from stock option exercises
increase in cash flows from changes in assets and liabilities, net of acquired assets:
payments related to business acquisitions and asset acquisitions, net of cash acquired
repurchase of common stock																																											0	0	0	-16,862,000	-5,827,000	0	-18,997,000	-25,732,000																								0	0	-4,442,000	-3,406,000	-32,624,000
effect of exchange rate changes
on cash and cash equivalents																																													841,000	122,000	-272,000	1,152,000	-1,028,000	-337,000	-1,957,000	-680,000	-795,000	501,000	-282,000	-1,743,000	355,000	750,000	-470,000			-179,000		-1,210,000	171,000	-316,000	800,000	141,000	1,596,000		1,986,000	1,055,000	458,000	1,271,000	790,000	839,000	160,000
net decrease in cash and cash equivalents																																				3,653,000	3,401,000	-52,610,000
adjustments to reconcile net income
to net cash from operating activities:
increase in cash flows
from changes in assets and liabilities, net of acquired assets:
payments on senior credit agreement																																					-2,188,000	-2,188,000													0	-21,525,000	-31,725,000	-338,000	21,663,000	-338,000			-338,000	9,663,000			-337,000							-19,336,000	1,662,000			-31,338,000	-338,000			-647,000
proceeds from senior credit agreement																																					10,000	253,005,000		2,000,000	2,000,000	17,000,000		2,000,000	4,000,000	27,000,000		-9,000,000	9,000,000	64,000,000		23,000,000	7,000,000	50,000,000
income tax benefit of stock
option exercises
excess tax benefit from stock
liabilities, net of effects from acquisitions:
payments related to business acquisitions and asset acquisitions,
net of cash acquired
net proceeds from common stock issued
under employee plans																																															4,237,000	2,661,000	2,733,000	7,633,000	751,000	1,546,000	2,523,000	5,345,000	358,000	264,000			1,500,000							299,000	6,453,000				515,000			628,000	865,000
proceeds of senior credit agreement																																																											5,000,000				-2,000,000	-3,000,000	12,000,000									0	0			37,000,000
payments on senior subordinated notes																																																											0	0			0
from changes in assets and liabilities, net of acquisitions:
income taxes receivable																																								953,000	-1,780,000	675,000		1,904,000	-2,839,000	1,826,000		-2,091,000	-1,415,000	244,000															-2,141,000				1,841,000	5,022,000	-95,000	-707,000	-1,102,000
payments related to business acquisitions																																								0																0	0	-72,000		-69,000	-74,000	-5,083,000	-74,000	-76,000	-112,000		-195,000	-7,080,000	-14,758,000		-4,559,000	-395,000	-883,000		-5,000
net proceeds from common stock issued under employee plans																																								196,000	287,000	181,000		763,000	224,000	729,000												1,287,000
payment related to contingent consideration																																								0
from changes in assets and liabilities:
payments related to a business acquisition																																										-853,000
payments related to business acquisitions and distribution agreements,
proceeds from sale of property
payments related to issuance of debt																																															0	0	-89,000	-1,636,000
27,926
payments on mortgage note
3,129
payment related to distribution agreement																																													0	-16,667,000		0	0	-34,000,000
(5,020																																														8,399,000
amortization, all other																																																			7,229,000	6,962,000	6,666,000	7,124,000	5,501,000	4,907,000	5,027,000	4,830,000	5,107,000	5,040,000	4,941,000	5,083,000	4,580,000	4,705,000	4,395,000
impairment of goodwill
102,241
net increase in cash
and cash equivalents
supplemental disclosures of cash flow information:
cash paid during the year for:
interest
31,679
payment related to senior subordinated notes																																																0
13,013
(2,339																																																		-5,020,000
sale of accounts receivable to (collections
on behalf of) purchaser
7,897
stock-based compensation expense																																																				1,541,000	1,391,000	1,183,000		1,482,000
50,823
payments related to business acquisitions and distribution agreement, net of cash acquired
repurchase of treasury stock																																																											0	-13,506,000
net cash provided by
(used in) financing activities																																																				-633,000	-22,889,000	55,816,000		-15,095,000											-662,000
income taxes payable																																																					-3,357,000	-1,232,000		686,000	-190,000	333,000		-454,000	495,000	-620,000	-565,000											35,000	0	-526,000	-1,453,000	-468,000
22,548
payments related to business acquisitions and distribution agreement																																																					0	-64,116,000
11,705																																																						-2,339,000
(gain) loss on extinguishment of debt
increase in cash flows from
changes in assets and liabilities
of effects from acquisitions:
12,891
payments related to intangible assets and business acquisitions,
net change in cash overdrafts																																																							0	0	-3,485,000	337,000	-2,352,000	4,486,000	463,000	-2,531,000	-673,000	1,585,000	-3,164,000					0	-1,534,000	1,458,000	-1,694,000	1,770,000	0	-421,000	-183,000
sale of accounts receivable to
(collections on behalf of) purchaser
(8,093
proceeds from secured borrowings																																																												-7,000,000	-2,000,000	33,000,000
sale of accounts receivable to (collections on
behalf of) purchaser																																																														-29,000,000
payments on long term debt																																																										-13,337,000				-9,337,000			-7,913,000				-125,000				-7,791,000				-6,465,000
payments related to business acquisitions,
adjustments to reconcile net income, to net cash from operating activities:
(gain) loss on early extinguishment of debt																																																												0
purchases of property, plant, and equipment																																																												-3,692,000			-5,058,000				-6,640,000				-6,408,000				-6,491,000
gain on early extinguishment of debt																																																															0	0	-1,083,000
operating activities																																																														-12,932,000
net proceeds from common stock issued under
employee plans																																																														267,000			110,000				221,000				3,268,000				772,000
proceeds of long term debt
sale of accounts receivable to (collections on behalf of) purchaser
purchaser																																																																-1,000,000	-2,000,000
pension gain																																																																	-1,882,000
goodwill impairment
sale of accounts receivable																																																																		2,000,000	-2,000,000	-6,000,000	3,000,000	5,000,000	-6,000,000	-1,000,000	3,000,000	7,000,000			-3,000,000	-3,000,000
contributions to pension plans less than
(in excess of) net pension cost
gain on extinguishment of debt
proceeds from sale of equity investment																																																																										0	0	0	1,205,000
adjustments to reconcile net income,
gain on legal settlement																																																																									-6,072,000
accrued interest																																																																					915,000	-1,206,000	1,115,000	-1,200,000	1,259,000	-1,212,000	831,000	-1,765,000	1,778,000	-720,000
financing activities																																																																					96,000
contributions to pension plans less than (in excess of) net pension cost
loss on extinguishment of debt																																																																										0	-273,000
loss on sale of equity investment
increase in cash flows from changes in assets and liabilities, net of effects from acquisitions:
excess tax benefits from stock-based compensation																																																																										37,000	70,000	19,000	13,000
payments related to issuance of long-term debt																																																																											0
stock option expense																																																																									852,000			771,000	814,000
excess tax benefits from stock-based
compensation																																																																										-37,000	-70,000	-19,000	-13,000
net pension cost
write-off of purchased in-process
research and development assets
proceeds from issuance of 2.50% convertible
senior subordinated notes
net cash from financing
activities
net increase in
cash and cash equivalents
cash and cash equivalents at beginning
of year
income tax benefit of
stock option exercises																																																																												19,000	13,000
net increase in cash and cash equivalent
write-off of purchased in-process research and development assets
write-off of deferred financing costs
other investing activities
redemption of 9.0% senior subordinated notes
see notes to consolidated financial statements.
write-off of purchased in-process research and
development assets
net cash provided byfinancing activities
net increase(decrease) in cash and cash equivalents

We provide you with 20 years of cash flow statements for CONMED stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CONMED stock. Explore the full financial landscape of CONMED stock with our expertly curated income statements.

The information provided in this report about CONMED stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.